Skip to main content

and
  1. No Access

    Article

    Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide

    To investigate the pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia (APL) treated with arsenic trioxide (ATO) at a daily dose of 0.15 mg/kg.

    Shinya Fujisawa, Ryuzo Ohno, Kazuyuki Shigeno in Cancer Chemotherapy and Pharmacology (2007)

  2. No Access

    Article

    Acute myelogenous leukemia with t(6;9)(p23;q34): Report of three patients

    Acute myelogenous leukemia (AML) with the translocation t(6;9)(p23;q34) is a rare disease entity with a poor prognosis. We report three patients; two were diagnosed with AML of French-American-British (FAB) C...

    K. Yano, Hirotaka Matsui, Yasuyuki Nakano in International Journal of Clinical Oncology (1999)